|
Volumn 177, Issue 12, 2001, Pages 681-682
|
Commentary;Kommentar
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER CONTROL;
CANCER RADIOTHERAPY;
CANCER REGRESSION;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL TRIAL;
HUMAN;
META ANALYSIS;
NOTE;
PREOPERATIVE PERIOD;
RECTUM CARCINOMA;
SURGICAL TECHNIQUE;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ADENOCARCINOMA;
ARTICLE;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
PATIENT COMPLIANCE;
PREOPERATIVE CARE;
RADIATION DOSE;
RANDOMIZED CONTROLLED TRIAL;
RECTUM TUMOR;
RISK;
SURVIVAL;
TUMOR RECURRENCE;
ADENOCARCINOMA;
COMBINED MODALITY THERAPY;
HUMANS;
META-ANALYSIS;
NEOPLASM RECURRENCE, LOCAL;
ODDS RATIO;
PATIENT COMPLIANCE;
PREOPERATIVE CARE;
RADIOTHERAPY DOSAGE;
RANDOMIZED CONTROLLED TRIALS;
RECTAL NEOPLASMS;
SURVIVAL ANALYSIS;
|
EID: 0035664313
PISSN: 01797158
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (4)
|
References (2)
|